Showing 1,539 results

Filters Content type: News, Editors' picks, About HIV Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

Access to healthcare

AHF Praises J&J for AIDS Drug Price Cut, Asks Merck to Follow Suit

Editor's pick
Yahoo News
8 December 2011
Access to healthcare

Johnson & Johnson shuns poor people with HIV

Editor's pick
New Internationalist
8 December 2011
Pharmaceutical industry

Theratechnologies to discontinue COPD clinical program and focus on lipodystrophy

Editor's pick
Theratechnologies press release
8 December 2011
Pharmaceutical industry

Gilead Bonds Expose Discontent Shares Conceal: Corporate Finance

Editor's pick
Bloomberg Business Week
7 December 2011
Pharmaceutical industry

Pharmasset Poised to Pay 20% With Gilead Deal Closing

Editor's pick
Bloomberg Businessweek
6 December 2011
New & experimental HIV treatments

Boosting Agent Cobicistat Comparable to Norvir in Phase III Study

Editor's pick
AIDSMeds
6 December 2011
Pharmaceutical industry

Ending HIV/AIDS: Hedge Funds Believe in These 5 Companies

Editor's pick
Motley Fool
5 December 2011
Access to healthcare

Tanzania sets up production plant for HIV/AIDS medication

Editor's pick
Deutsche Welle
3 December 2011
New & experimental HIV treatments

Nearly 90 Medicines and Vaccines In Development for HIV/AIDS

Editor's pick
Pharmiweb
1 December 2011
Access to healthcare

Mylan Receives Tentative FDA Approval Through PEPFAR for First Heat-Stable, Fixed-Dose Combination of Atazanavir Sulfate and Ritonavir Tablets for HIV/AIDS

Editor's pick
Press release
1 December 2011
Sexually transmitted infections prevention

UK switches to Merck's Gardasil for HPV vaccination

Editor's pick
Reuters
26 November 2011
Pharmaceutical industry

HIV Drug Giant Gilead Acquires Pharmasset, a Hep C Drug Development Leader

Editor's pick
AIDSMeds.com
21 November 2011
Access to healthcare

SOUTH AFRICA: Activists urge change to patent laws

Editor's pick
IRIN Plus News
21 November 2011
Access to healthcare

$100,000 Gates Foundation Grant to Reduce HIV Drug Prices

Editor's pick
Poz magazine news
17 November 2011
Pharmaceutical industry

HIV Experts Urge Better Management of HIV/AIDS Medicines in Latin America and Caribbean

Editor's pick
Pharm Pro
16 November 2011
Access to healthcare

KENYA: Local production means cheaper ARVs

Editor's pick
IRIN Plus News
16 November 2011
Pharmaceutical industry

Complete One-Pill, Once-Daily Prezista-Based HIV Regimen Enters Development

Editor's pick
AIDSMeds
16 November 2011
Pharmaceutical industry

Gilead and J&J expand HIV cocktail partnership

Editor's pick
CNBC
15 November 2011
Access to healthcare

BMS boosts access to HIV drug Reyataz in Brazil

Editor's pick
InPharm
14 November 2011
Access to healthcare

Bristol-Myers Squibb Signs New Agreement to Expand Access to Reyataz® (atazanavir sulfate) in Brazil

Editor's pick
Bristol-Myers Squibb press release
14 November 2011
Access to healthcare

Public Health Groups Launch Global Campaign Against Abbott Labs’ Monopoly on Critical AIDS Medicine

Editor's pick
Public Citizen
10 November 2011
Pharmaceutical industry

No to Obama's pharma in Asia

Editor's pick
Bangkok Post
6 November 2011
Access to healthcare

Glaxo-Pfizer HIV venture plans Russian manufacturing

Editor's pick
Yahoo News
2 November 2011
Pharmaceutical industry

Kenya: ARVs to Cost 30 Percent Less As WHO Clears Manufacturer

Editor's pick
AllAfrica
2 November 2011